Products
Online Inquiry
8-iso-16-cyclohexyl-tetranor PGE2
Cat. No.:
OB0626WX-2923
Appearance:
Liquid
Purity:
≥97%
Identity:
Confirmed by TLC and HPLC.
Size:
Add to basket
Product Overview
Description:
8-iso-16-cyclohexyl-tetranor PGE2 is a synthetically modified prostanoid analogue designed as a structurally constrained derivative of the lipid peroxidation product 8-iso prostaglandin E2. Featuring a terminal cyclohexyl ring modification paired with chain shortening, this unique eicosanoid scaffold serves as a specialized template for exploring structural-activity relationships within non-enzymatic prostanoid pathways.
Synonyms:
9-oxo-11α,15S-dihydroxy-(8β)-16-cyclohexyl-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-oic; 8-iso-16-cyclohexyl-tetranor Prostaglandin E2; 53319-30-5; (Z)-7-[(1S,2R,3R)-2-[(E,3S)-4-cyclohexyl-3-hydroxybut-1-enyl]-3-hydroxy-5-oxocyclopentyl]hept-5-enoic acid; (Z)-7-[(1S,2R,3R)-2-[(E,3S)-4-cyclohexyl-3-hydroxy-but-1-enyl]-3-hydroxy-5-oxo-cyclopentyl]hept-5-enoic acid
CAS No.:
53319-30-5
Compound CID:
35027958
Formula:
C22H34O5
Formula Weight:
378.5
Specification
Solubility in DMSO:
50 mg/mL
Solubility in Ethanol:
50 mg/mL
Solubility in DMF:
50 mg/mL
Solubility in Other Solvents:
PBS: 1 mg/mL
Storage:
Storage at -20°C.
Applications:
8-iso-16-cyclohexyl-tetranor PGE2 serves as a prostaglandin analog reference compound for eicosanoid research, structural characterization, and comparative analysis of modified prostanoid derivatives. It supports lipid mediator profiling and biochemical studies involving prostaglandin-related compounds.
